Mesoblast | MSB - Sales Revenues


Mesoblast reported $63.9M in Sales Revenues for its fiscal semester ending in June of 2026.





Sales Change Date
Avita Medical AUD 17.61M 805K Dec/2025
Clinuvel Pharmaceuticals AUD 36.93M 22.44M Dec/2025
Cochlear AUD 1.18B 590.35M Dec/2025
CSL USD 8.33B 4.79B Dec/2025
Pacific Edge NZD 5.56M 379K Jun/2026
Paradigm Biopharmaceuticals AUD 284.06K 292.06K Dec/2025
PYC Therapeutics AUD 11.04M 2.44M Dec/2025
Ramsay Health Care AUD 9.24B 100M Dec/2026
Sonic Healthcare AUD 5.42B 30M Jun/2026
Starpharma Holdings AUD 10.83M 9.12M Dec/2025
Telix Pharmaceuticals AUD 477.35M 63.92M Jun/2026